A clinical reason why Mercy’s bold move on Eversense 365 could ignite a wave of new healthcare network partnerships

I’ve been in the blood glucose diagnostics field for over 10 years, and the Mercy Health deal is a big move. This isn’t just another business partnership — it’s a shift that could trigger a wave of similar deals in the near future. Here’s why it matters.

Unlike most other conditions, managing diabetes depends almost entirely on the patient. Blood glucose monitoring (BGM) isn’t something that can be tracked passively like heart rate or blood pressure. It requires patients to actively check their levels and report back, while also managing daily factors like sleep, meals, and exercise that affect their glucose. This makes it hard for healthcare providers to get a full, accurate picture of what’s going on.

CGMs (continuous glucose monitors) were supposed to address these issues, and to some extent, they have. But they come with their own set of problems. Sensors can fall off, patients are not intend to reattach them immediately, and data issues like false reading, outliers make the data less reliable. As a result, healthcare providers often end up relying on old-school BGM to fill in the blanks, which isn’t exactly “continuous” monitoring.

This is where Eversense 365 makes a real difference. Instead of a patch-style sensor that sticks to the skin, it stays in place for a full year. No dislodging, no reattaching, and no worries about it getting knocked off. It gives glucose readings every 5 minutes, 24/7, for a whole year. That level of consistency and continuity is a game-changer for both patients and providers. It’s no surprise that Mercy Health, a healthcare provider with $8 billion in annual revenue, made the move to partner with them.

But what really pushes Eversense 365 ahead is its new calibration schedule. The old version required 1-2 daily calibrations, which was a pain point for a lot of users and huge burden to adoption. But now, it is once a week. HCPs say the reaction from patients are completely different now because the daily calibration was actually a huge deal for them.

For healthcare providers like Mercy Health, this means better data reliability and fewer gaps. Continuous, uninterrupted data allows for more accurate insights and better treatment decisions. From a strategic perspective, it’s easy to see why Mercy Health wanted to be at the front of this shift. With Eversense 365, they get more consistent data, patients get a simpler experience, and both sides benefit.

This deal feels like the start of a larger trend. As more healthcare providers see the potential of a system that offers long-term, low-maintenance, continuous glucose data, other partnerships are likely to follow. The industry is always looking for ways to reduce patient burden and improve clinical outcomes, and Eversense 365 checks both boxes. It’s only a matter of time before other major networks jump on board.